The US is the bigger Anti-Aging market: $37 Bn against $1.6 Bn in 2023, about 23 times as large.
India grows faster: 11.1% a year, against 6.1%. The gap still grows from $35.4 Bn to $62.4 Bn by 2033.
Clinical research: 1,028 active trials in the US, 9 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $37 Bn | $1.6 Bn |
| Market size, 2033 projected | $67 Bn | $4.6 Bn |
| Growth a year (CAGR) | 6.1% | 11.1% |
| Money added, 2023–2033 | $29.9 Bn | $3 Bn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $108 | $1.10 |
| Active clinical trials | 1,028 | 9 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Anti-Aging, US or India?
The US is the bigger Anti-Aging market: $37 Bn against $1.6 Bn in 2023, about 23 times as large.
Which grows faster in Anti-Aging, US or India?
India grows faster: 11.1% a year, against 6.1%. The gap still grows from $35.4 Bn to $62.4 Bn by 2033.
More Anti-Aging comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.